Loading…
Lincoln Pharmaceuticals (LINCOLN)₹520.85+1.39%Pharmaceuticals
At the end of the Sep 2026 quarter, Lincoln Pharmaceuticals' shareholders were: promoters 49.74%, FIIs 4.59%, DIIs 0.02%, public 45.65%. Promoter holding is unchanged on the quarter. FII holding is down 0.18 percentage points from 4.77% a year earlier. It had 29,284 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 49.77% | 49.50% | 49.74% | 49.74% | 49.74% | 49.74% | 49.74% | 49.74% | 49.74% | 49.74% | 49.74% | 49.74% |
| FIIs | 3.25% | 3.96% | 3.98% | 5.23% | 5.20% | 5.04% | 5.17% | 4.77% | 4.74% | 5.24% | 4.64% | 4.59% |
| DIIs | 0.06% | 0.05% | 0.04% | 0.00% | 0.00% | 0.00% | 0.01% | 0.01% | 0.01% | 1.07% | 0.27% | 0.02% |
| Public | 46.92% | 46.49% | 46.24% | 45.03% | 45.06% | 45.22% | 45.08% | 45.48% | 45.51% | 43.95% | 45.35% | 45.65% |
| Number of shareholders | 29,328 | 31,388 | 29,979 | 31,343 | 31,861 | 31,880 | 31,797 | 32,383 | 31,039 | 28,315 | 29,408 | 29,284 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Munjal Mahendrabhai Patel | Promoter | 13.33% | 0.00 |
| Ashish Rajanikant Patel | Promoter | 10.58% | 0.00 |
| Rajanikant Gulabdas Patel | Promoter | 3.77% | 0.00 |
| Mahendrabhai Gulabdas Patel | Promoter | 3.39% | 0.00 |
| Sunmed Corporation Llp | Promoter | 2.48% | 0.00 |
| Kishor M. Shah | Public | 2.40% | 0.00 |
| Kailashben Mahendrabhai Patel | Promoter | 2.39% | 0.00 |
| Downtown Travels Llp | Promoter | 2.35% | 0.00 |
| Hasmukhbhai Ishwarbhai Patel | Promoter | 1.86% | 0.00 |
| Anand Arvinbhai Patel | Promoter | 1.67% | 0.00 |
| Rimo Capital Fund Lp | FII | 1.34% | 0.00 |
| Dheeraj Kumar Lohia | Public | 1.23% | 0.00 |
| Shivani Ashish Patel | Promoter | 1.02% | 0.00 |
| Mansi Munjal Patel | Promoter | 1.01% | 0.00 |
| Hansaben Arvindbhai Patel | Promoter | 0.89% | 0.00 |
| Patel Nishitkumar Maheshbhai | Promoter | 0.77% | 0.00 |
| Dharmisthaben Bhagirath Patel | Promoter | 0.62% | 0.00 |
| Arvindbhai Gulabdas Patel | Promoter | 0.55% | 0.00 |
| Downtown Finance Pvt. Ltd. | Promoter | 0.53% | 0.00 |
| Renukaben Maheshbhai Patel | Promoter | 0.49% | 0.00 |
| Jigar Hasmukhbhai Patel | Promoter | 0.43% | 0.00 |
| Patel Aniruddh H | Promoter | 0.43% | 0.00 |
| Mihir Viththalbhai Patel | Promoter | 0.41% | 0.00 |
| Dharmistaben Hasmukhbhai Patel | Promoter | 0.32% | 0.00 |
| Nidhi Mahendrabhai Patel | Promoter | 0.27% | 0.00 |
Promoters held 49.74% of Lincoln Pharmaceuticals at the end of the Sep 2026 quarter, the same as a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 4.59% (down 0.05 percentage points from 4.64% a quarter earlier) and domestic institutions (DIIs) held 0.02% (down 0.25 percentage points from 0.27% a quarter earlier).
Lincoln Pharmaceuticals had 29,284 shareholders at the end of the Sep 2026 quarter, against 32,383 a year earlier.
Kishor M. Shah (Public) held 2.40% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.